Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Test-Retest Reliability of Grip Force Sense for Proprioception Assessment

NCT07334808 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-01-13
Last updated
2026-01-15

Condition(s) studied

Healthy Volunteers

Study summary

The aim of this study is to investigate the test-retest reliability of the grip force sense, a component of proprioception, using a dynamometer that is easily accessible and usable in a clinical setting. This provides an accessible assessment method for research in the field of proprioception.

Eligibility

Sex
ALL
Min age
18 Years
Max age
24 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18-24 years * Volunteering to participate Exclusion Criteria: * Having a history of hand surgery * Having any active pathology or pain complaints in the hand

Primary outcome measure(s)

  • Absolute Error (AE) — Baseline and 1 week
    Absolute Error (AE) represents the absolute difference between the target force and the reproduced force, without regard to direction. It reflects the overall accuracy of the force reproduction task.
  • Constant Error (CE) — Baseline and 1 week
    Constant Error (CE) represents the directional difference between the target force and the reproduced force. It indicates the participant's directional bias (overshooting or undershooting the target).
  • Variable Error (VE) — Baseline and 1 week
    Variable Error (VE) represents the variability or consistency of the participant's performance across trials, regardless of the target. It reflects the consistency of force reproduction.

Trial sites (1)

FacilityCityRegionStatus
Kutahya Health Science University Kütahya Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07334808 on ClinicalTrials.gov ↗ ← All trials in Turkey